Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Yael L. Maxwell

August 14, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

L.A. McKeown

January 30, 2024

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Daily News

Statin Therapy Still Lacking for Many US Patients With ASCVD

L.A. McKeown

August 07, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2023

Shelley Wood

April 28, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests

L.A. McKeown

September 16, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey

Caitlin E. Cox

April 26, 2022

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

New ACC/AHA Hypertension Guidelines Still Urge Early Treatment but With Some Twists

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Semaglutide Has Similar Benefits in Women and Men With HFpEF

AHA Celebrates a Century by Looking Back, and Forward

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

GDMT Rates Low in HFrEF, Particularly in Women

Mortality Risk Varies Among Patients With Very High LDL Levels

Statin Therapy Still Lacking for Many US Patients With ASCVD

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

TCTMD’s Top 10 Most Popular Stories for April 2023

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests

Good News and Bad for High-Intensity Statin Use in ASCVD

Cardio-Obstetrics Merits Better Training, Wider Uptake: Survey

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content